SpringWorks Therapeutics - Stock Price History | SWTX

Historical daily share price chart and data for SpringWorks Therapeutics since 2022 adjusted for splits. The latest closing stock price for SpringWorks Therapeutics as of May 23, 2022 is 38.00.
  • The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
  • The SpringWorks Therapeutics 52-week high stock price is 89.75, which is 136.2% above the current share price.
  • The SpringWorks Therapeutics 52-week low stock price is 33.33, which is 12.3% below the current share price.
  • The average SpringWorks Therapeutics stock price for the last 52 weeks is 65.42.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
SpringWorks Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 74.3153 68.9700 93.5900 53.3000 61.9800 -14.53%
2020 43.9053 35.1600 77.9200 20.4400 72.5200 88.41%
2019 23.4396 22.6300 39.5200 17.7400 38.4900 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.838B $0.035B
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00